Drug Discovery World

FEBRUARY 6, 2024

These events feature presentations by leading experts in various aspects of drug discovery, covering topics such as target identification and validation, high-throughput screening, assay development, and data analysis. Researchers gain insights into the latest trends, methodologies, and discoveries shaping the field.

Medical Schools 147

Medical Schools Clinical Trials Assay Development Hospitals 147

PPD

OCTOBER 18, 2023

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. 1 With this growth comes increased demands for laboratory services at all steps across the development process. Stay ahead of the curve with a great GMP/CMC contract laboratory partner.

Laboratories 52

Laboratories Assay Development Small Molecule Packaging 52

Drug Discovery World

JUNE 12, 2023

Those are the beginning of additional manufacturing, scale of chemistry pharmacokinetics, pharmacology assays, development bioanalytical assays, and then moving forward toxicology work to start the initial clinical trials.

Research 130

Research Clinical Trials Doctors Assay Development 130

Broad Institute

OCTOBER 17, 2023

Christian Soule By Rose Circeo October 17, 2023 Rees MG, Seashore-Ludlow B, Cheah JH, et al. He utilized industry-leading laboratory technology to design robust, repeatable experiments, including assay development, training, large screens, and follow-up assays. Nat Chem Biol. 2016;12(2):109-116. doi:10.1038/nchembio.1986

Assay Development 52

Assay Development Laboratories Engineering Science 52

Drug Discovery World

AUGUST 29, 2024

Machine learning informs media exchange, plating, passaging, organoid monitoring, endpoint assays, and complex image analysis, increasing productivity and reproducibility for drug screening. The kits use the CaptSure system, a semi-homogeneous system that forms the antibody-analyte sandwich complex in solution.

Small Molecule 147

Small Molecule Drugs Protein Expression Assay Development 147

Drug Discovery World

OCTOBER 13, 2022

Meanwhile, Stratech Bio were on hand to answer enquiries about their range of raw materials, kits and assays for R&D or bioprocessing projects. Not to mention, the 2023 calendar which, if the year-on-year trajectory continues in the same way as Drug Discovery 2022, should be a landmark year for drug discovery. .

Drugs 130

Drugs Cell Based Assays Science Assay Development 130

Drug Target Review

OCTOBER 3, 2024

This comprehensive toolbox of Type 1, Type 2, Type 3 and Type 4 anti-idiotypic antibodies provides PK and ADA assay developers with enhanced flexibility for a thorough analysis of antibody candidates. Adapted from Harth S et al. (8) 8) under a CC BY-NC-ND 4.0. Crescioli S, Kaplon H, Chenoweth A, et al. Antibodies to watch in 2024.

Molecular Biology 52

Molecular Biology Pharmacokinetics Laboratories Animal Testing 52

Alta Sciences

AUGUST 21, 2023

Choosing the Best Bioanalytical Platform for Your Program aasimakopoulos Mon, 08/21/2023 - 20:50 Choosing the right bioanalytical platform for your molecule’s intended use and program segment is crucial to obtaining reliable, robust data in a timely manner. Why Partner With Altasciences for Your Bioanalytical Projects?

Assay Development 52

Assay Development Pharmacokinetics Drug Development Drugs 52

Drug Discovery World

APRIL 21, 2023

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. The project is based on the phase-imaging technology developed in the research group led by ICREA Professor at ICFO Dr Valerio Pruneri, and is being incubated in the KTT Launchpad at ICFO.

Cell Based Assays 130

Cell Based Assays Targeted Protein Degradation Assay Development Doctors 130

Drug Discovery World

JUNE 14, 2023

In acknowledgement of Blood Donor Day 2023, DDW spoke with industry experts about the significance of blood donorship in drug discovery. Bill Block, President & CEO of Blood Centers of America Bill Block is President and CEO of Blood Centers of America (BCA). umbilical cord blood, leukopaks, HSCs, MSCs, PBMCs, NK, and T cells).

Therapies 130

Therapies Production Hospitals Treatment 130

Drug Discovery World

MARCH 4, 2024

The advantage of this approach is that users can easily integrate assay annotation into their normal workflow, even sharing the annotation information with other applications using CDD Vault’s API. DDW Volume 25 – Issue 1, Winter 2023/2024 Biography Abraham Wang is the Head of Marketing at Collaborative Drug Discovery.

Drugs 147

Drugs Drug Development Compliance Research 147

FDA Law Blog: Drug Discovery

JANUARY 4, 2023

The purpose of these town halls are to discuss topics related to OTAT-regulated products, engage with product development stakeholders, and to provide information to help stakeholders to help advance drug development. The next town hall will focus on the clinical development of gene therapy products for rare diseases in February 2023.

Therapies 59

Therapies Engineering Production FDA 59

Drug Discovery World

DECEMBER 28, 2022

The use of biomarkers in biotherapeutic development continues to increase. The introduction of plug and play kits is designed to increase the utility of the platform by removing the timelines needed for assay development. . The deadline for applications is January 31, 2023.

Production 242

Production Compliance Assay Development RNA 242

Drug Discovery World

JANUARY 19, 2023

This paid-for advertorial by Catalent appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 One significant challenge in the manufacturing of cell and gene therapies is the production of high-quality plasmid DNA (pDNA).

DNA 130

DNA Therapies Assay Development Production 130

Drug Discovery World

FEBRUARY 21, 2023

Ashwin Pillai is Test Engineer 3 in HTS & Assay Development at Ginkgo Bioworks, a company whose mission is to make biology easier to engineer. SLAS 2023 Supplement, Volume 24 – Issue 1, Winter 2022/2023 Biography Ashwin Pillai works at Ginkgo Bioworks in Boston, as an Automation Scientist in the High Throughput Screening group.

Bioinformatics 130

Bioinformatics Assay Development Engineering Drugs 130

Agency IQ

JULY 21, 2023

BY RACHEL COE, MSC JUL 18, 2023 11:14 PM CDT Oncology endpoints: The growing pains of an evolving field FDA approval of a drug or biologic relies on whether there is “substantial evidence” of safety and effectiveness derived from “adequate and well-controlled clinical investigations” according to the Federal Food, Drug, and Cosmetic (FD&C) Act.

FDA 40

FDA Clinical Trials Treatment DNA 40

Broad Institute

JUNE 30, 2023

LipocyteProfiler builds on the concept of image-based profiling that was first introduced in the context of morphology mapping by Cell Painting, a high-content imaging assay developed by Broad institute scientist and Imaging Platform senior director Anne Carpenter. Online June 20, 2023. Papers cited Laber S, Strobel SM, et al.

Small Molecule 105

Small Molecule Cell Based Assays Disease Assay Development 105

Drug Discovery World

APRIL 25, 2024

According to Grand View Research, the global cell line development market was valued at $4.81 billion in 2022, a figure that is expected to grow at a compound annual growth rate (CAGR) of 9.81% from 2023 to 2030 1.

Vaccine 147

Vaccine Production Pharmaceuticals Therapies 147

Drug Discovery World

MAY 11, 2023

This approval could pave the way for LC-MS to transition more frequently into a good manufacturing process (GMP) environment, where it can be used as a release assay for regulatory documentation. LC-MS can prove valuable not only in quality control, but also in early development phases. S SARS-CoV-2 vector vaccines.” 2022): 947.

Production 130

Production Vaccine Immune Response Therapies 130

Elrig

APRIL 29, 2024

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

FEBRUARY 15, 2023

In this era of precision/personalised medicine, identifying predictive or prognostic biomarkers and devising single or combination therapies that combine safety and efficacy in population groups with refractory cancer is not beyond reach, but we must develop robust models to test them, and the CRO environment is the ideal setting to achieve this.

Research 130

Research Therapies Immune Response Clinical Trials 130

Agency IQ

FEBRUARY 2, 2024

The protocol and statistical analysis plan should clearly specify the plans for specimen collection, sample analysis and related clinical outcomes depending on the biomarker assay development and validation strategy. Second, the EMA is working on a separate guideline for platform trials , floating a concept paper in 2022.

Clinical Trials 40

Clinical Trials Trials Treatment Production 40